Standards
Editorial policy
Our editorial policy explains how we choose sources, how we update pages, and the boundaries we keep when writing about medicines and providers.
Quick answer
Our editorial policy explains how we choose sources, how we update pages, and the boundaries we keep when writing about medicines and providers.
Purpose
This editorial policy sets out how SlimBee chooses topics, cites sources, updates pages, and refuses common shortcuts that look impressive online but mislead UK readers about medicines, access, and risk. The policy exists because weight management is a Your Money or Your Life (YMYL) topic: mistakes can change behaviour, spending, and safety.
Independence and conflicts
SlimBee does not sell medicines, take commission on prescriptions, or accept payments that would influence ranking tables. If we ever run clearly labelled sponsorship for non-editorial placements, it will be separated from comparisons and disclosed in plain English. Editorial decisions are judged against reader benefit, verifiability, and regulatory realism, not headline traffic alone.
Sources we trust first
We prioritise primary UK sources such as NHS condition pages, NICE guidance and technology appraisals where relevant, MHRA safety communications and product information, and professional regulator registers. We may reference peer-reviewed summaries when they help explain mechanisms or typical trial outcomes, but we avoid treating single studies as universal truth. Social media anecdotes, influencer claims, and anonymous forums are not acceptable evidence for medical assertions.
How we describe evidence
When we summarise trials, we describe populations, durations, endpoints, and average effects. We avoid language that implies guaranteed personal outcomes. We distinguish between biological plausibility, clinical trial results, and real-world practice where access, adherence, and comorbidities shift outcomes. If uncertainty is high, we say so plainly rather than smoothing it away for readability.
Safety boundaries for medicines
SlimBee does not publish personalised dosing instructions, taper schedules, or “how to get a prescription” workarounds that bypass clinical safeguards. We do not encourage sharing or buying medicines from unregulated sources. We do not invent named clinical reviewers. If we quote public guidance, we attribute it and link out where possible so readers can read the full context.
Price and provider comparisons
Prices on third-party sites move with stock, dose, delivery, and policy changes. We treat listed figures as orientation and remind readers to confirm totals at checkout. When we describe pharmacy models, we aim for neutral structural explanations rather than promotional tone. If a provider disputes a structural description, we review verifiable evidence such as regulator listings and published terms.
Corrections and versioning
We correct factual errors when verified. For YMYL pages, we aim to patch quickly and record what changed when the change affects clinical or financial decisions. Typos that do not change meaning may be fixed silently. If guidance changes nationally, we update affected pages even if the old wording was once accurate.
Accessibility and inclusive language
We aim for respectful language that does not blame individuals for systemic drivers of weight change. We write readable sentences, meaningful headings, and descriptive links where feasible. Accessibility issues reported by readers are treated as defects to fix, not edge cases to ignore.
Editorial complaints
If you believe SlimBee has misrepresented a source, contact us with specifics. We do not promise to agree with every complaint, but we do promise to read it carefully and to explain our reasoning when we decline a change.
Future features
If SlimBee adds tools such as calculators or checklists, they will be labelled with limitations, tested for basic usability, and reviewed for alignment with this policy.
Further UK context (evidence and expectations)
British readers often encounter marketing that compresses complex trial results into a single impressive percentage. Real bodies respond differently because adherence, sleep, stress, other medications, and social determinants of health all influence trajectories. Evidence still matters because it helps set realistic expectations and identify common risks that monitoring can mitigate. However, evidence is not destiny. A prescriber may reasonably choose not to prescribe, choose a different agent, or prioritise lifestyle and mental health support first, depending on individual context. When SlimBee uses the phrase evidence-backed, we mean that public-domain sources such as NHS summaries, NICE documents, MHRA product information, and peer-reviewed literature support the general statement, not that an outcome is guaranteed for you.
Practical note-taking for consultations
Write down your current weight trend only if you find it helpful clinically, not as a moral score. Track blood pressure at home only if your clinician has asked you to and has shown you how. Keep a list of allergies and intolerances. Note any family history that matters for cardiovascular risk. If you have disabilities that affect diet or exercise, mention them so advice can be adapted rather than generic.
Editorial independence
SlimBee is an independent UK information site. We are not a pharmacy, clinic, prescriber or regulator. Nothing here replaces personalised medical advice, emergency care, or your prescriber's instructions.